MedPath

The Effect of Angiotensin Convetring Enzyme Inhibitor on the Quality of Life of Non Hospitalized Patients With Cancer Cachexia in Shiraz University Clinics

Phase 3
Conditions
Gastric cancer.
Malignant neoplasm of stomach
Registration Number
IRCT2014050511375N3
Lead Sponsor
Shiraz University of Midical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: Patients with aged 40-80 years old; Patients with BMI less 18 and those with muscle wasting or only temporal wasting.

Exclusion Criteria

Patients unable to continue the treatment; Patients with BMI more 18 without temporal or muscle wasting; Those with GFR less 50 ml/min; Positive history of other co-morbidity diseases; Patients with Hb less 9; Patients unavailable for or incapable of filling out questionnaires at different intervals.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Before and 1 month and 2 months after intervention. Method of measurement: QLQ-C30 questionnaire.
Secondary Outcome Measures
NameTimeMethod
Body Mass Index. Timepoint: Bfore and 1 month and 2 months after intervention. Method of measurement: By BMI Formula.
© Copyright 2025. All Rights Reserved by MedPath